The incidence of risk factors for thrombophilia in young patients with venous thromboembolism and their monitoring in the anticoagulant clinic: a retrograde analysis of one-year outpatient treatment

• Published in: Zdravniški vestnik (Ljubljana, Slovenia : 1992) Slovenia : 1992), 2012-12, Vol.81 (SUPL II)
• Main Authors: Bricman, Irena Umek, Krstanoska, Frosina
• Format: Article
• Language: English
• ISSN: 1318-0347; 1581-0024; 1581-0224

Background: Venous thromboembolisms (VTE) are presented as venous thrombosis and/ or pulmonary embolisms. When there are no risk factors found VTE is idiopatic. Methods: We analysed data from 1 January 2011 to 31 December 2011.Only patients under 50 years of age and with VTE were selected. One month after discontinuation of anticoagulant therapy they were tested for thrombophilia and we recieved the data. Results: 47 patients under 50 years of age with VTE were treated in this period. 21/47 (45 %) completed the therapy and were tested for thrombophilia. 3/21 patients had lupus anticoagulants, 5/21 had active protein C resistance and were heterozygous for factor V Leiden mutation. Conclusions: Screening for trombophila in patients with VTE generally does not influence the duration of antiocoagulant therapy. Tests make sense in younger patients, in unusual sites of VTE, with positive family history of VTE and recurrent VTE.